SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001193125-16-446037
Filing Date
2016-02-01
Accepted
2016-02-01 16:01:30
Documents
45
Period of Report
2015-12-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-K d113219d10k.htm 10-K 750710
2 CERTIFICATION OF THE CHIEF EXECUTIVE OFFICER d113219dex311.htm EX-31.1 8744
3 CERTIFICATION OF THE CHIEF FINANCIAL OFFICER d113219dex312.htm EX-31.2 8497
4 CERTIFICATION OF THE CHIEF EXECUTIVE OFFICER d113219dex321.htm EX-32.1 3435
5 CERTIFICATION OF THE CHIEF FINANCIAL OFFICER d113219dex322.htm EX-32.2 3442
  Complete submission text file 0001193125-16-446037.txt   2551298

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT hppi-20151231.xml EX-101.INS 231301
7 XBRL TAXONOMY EXTENSION SCHEMA hppi-20151231.xsd EX-101.SCH 33543
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE hppi-20151231_cal.xml EX-101.CAL 33639
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE hppi-20151231_def.xml EX-101.DEF 132612
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE hppi-20151231_lab.xml EX-101.LAB 255531
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE hppi-20151231_pre.xml EX-101.PRE 181912
Mailing Address 324 SOUTH HYDE PARK AVENUE SUITE 350 TAMPA FL 33606
Business Address 324 SOUTH HYDE PARK AVENUE SUITE 350 TAMPA FL 33606 (813) 864-2559
HedgePath Pharmaceuticals, Inc. (Filer) CIK: 0001042418 (see all company filings)

IRS No.: 541641133 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-13467 | Film No.: 161377264
SIC: 8731 Services-Commercial Physical & Biological Research